Global Herpes Simplex Virus Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1734

The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. It is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes.
In 2018, the global Herpes Simplex Virus Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Herpes Simplex Virus Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Herpes Simplex Virus Treatment development in United States, Europe and China.

The key players covered in this study
Novartis
Pfizer
Abbott Laboratories
Sun Pharmaceuticals
Valeant Pharmaceuticals
Teva Pharmaceutical
Dr. Reddy’s Laboratories
Mylan
GlaxoSmithKline

Market segment by Type, the product can be split into
Oral
Injectable
Topical

Market segment by Application, split into
Hospital pharmacies
Online pharmacies
Retail pharmacies
Drug stores

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Herpes Simplex Virus Treatment status, future forecast, growth opportunity, key market and key players.
To present the Herpes Simplex Virus Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Herpes Simplex Virus Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Injectable
1.4.4 Topical
1.5 Market by Application
1.5.1 Global Herpes Simplex Virus Treatment Market Share by Application (2014-2025)
1.5.2 Hospital pharmacies
1.5.3 Online pharmacies
1.5.4 Retail pharmacies
1.5.5 Drug stores
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Herpes Simplex Virus Treatment Market Size
2.2 Herpes Simplex Virus Treatment Growth Trends by Regions
2.2.1 Herpes Simplex Virus Treatment Market Size by Regions (2014-2025)
2.2.2 Herpes Simplex Virus Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Herpes Simplex Virus Treatment Market Size by Manufacturers
3.1.1 Global Herpes Simplex Virus Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Herpes Simplex Virus Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Herpes Simplex Virus Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Herpes Simplex Virus Treatment Key Players Head office and Area Served
3.3 Key Players Herpes Simplex Virus Treatment Product/Solution/Service
3.4 Date of Enter into Herpes Simplex Virus Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Herpes Simplex Virus Treatment Market Size by Type (2014-2019)
4.2 Global Herpes Simplex Virus Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Herpes Simplex Virus Treatment Market Size (2014-2019)
5.2 Herpes Simplex Virus Treatment Key Players in United States
5.3 United States Herpes Simplex Virus Treatment Market Size by Type
5.4 United States Herpes Simplex Virus Treatment Market Size by Application

6 Europe
6.1 Europe Herpes Simplex Virus Treatment Market Size (2014-2019)
6.2 Herpes Simplex Virus Treatment Key Players in Europe
6.3 Europe Herpes Simplex Virus Treatment Market Size by Type
6.4 Europe Herpes Simplex Virus Treatment Market Size by Application

7 China
7.1 China Herpes Simplex Virus Treatment Market Size (2014-2019)
7.2 Herpes Simplex Virus Treatment Key Players in China
7.3 China Herpes Simplex Virus Treatment Market Size by Type
7.4 China Herpes Simplex Virus Treatment Market Size by Application

8 Japan
8.1 Japan Herpes Simplex Virus Treatment Market Size (2014-2019)
8.2 Herpes Simplex Virus Treatment Key Players in Japan
8.3 Japan Herpes Simplex Virus Treatment Market Size by Type
8.4 Japan Herpes Simplex Virus Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Herpes Simplex Virus Treatment Market Size (2014-2019)
9.2 Herpes Simplex Virus Treatment Key Players in Southeast Asia
9.3 Southeast Asia Herpes Simplex Virus Treatment Market Size by Type
9.4 Southeast Asia Herpes Simplex Virus Treatment Market Size by Application

10 India
10.1 India Herpes Simplex Virus Treatment Market Size (2014-2019)
10.2 Herpes Simplex Virus Treatment Key Players in India
10.3 India Herpes Simplex Virus Treatment Market Size by Type
10.4 India Herpes Simplex Virus Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Herpes Simplex Virus Treatment Market Size (2014-2019)
11.2 Herpes Simplex Virus Treatment Key Players in Central & South America
11.3 Central & South America Herpes Simplex Virus Treatment Market Size by Type
11.4 Central & South America Herpes Simplex Virus Treatment Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Herpes Simplex Virus Treatment Introduction
12.1.4 Novartis Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Herpes Simplex Virus Treatment Introduction
12.2.4 Pfizer Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Herpes Simplex Virus Treatment Introduction
12.3.4 Abbott Laboratories Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.3.5 Abbott Laboratories Recent Development
12.4 Sun Pharmaceuticals
12.4.1 Sun Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Herpes Simplex Virus Treatment Introduction
12.4.4 Sun Pharmaceuticals Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.4.5 Sun Pharmaceuticals Recent Development
12.5 Valeant Pharmaceuticals
12.5.1 Valeant Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Herpes Simplex Virus Treatment Introduction
12.5.4 Valeant Pharmaceuticals Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.5.5 Valeant Pharmaceuticals Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Herpes Simplex Virus Treatment Introduction
12.6.4 Teva Pharmaceutical Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.6.5 Teva Pharmaceutical Recent Development
12.7 Dr. Reddy’s Laboratories
12.7.1 Dr. Reddy’s Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Herpes Simplex Virus Treatment Introduction
12.7.4 Dr. Reddy’s Laboratories Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.7.5 Dr. Reddy’s Laboratories Recent Development
12.8 Mylan
12.8.1 Mylan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Herpes Simplex Virus Treatment Introduction
12.8.4 Mylan Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.8.5 Mylan Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Details
12.9.2 Company Description and Business Overview
12.9.3 Herpes Simplex Virus Treatment Introduction
12.9.4 GlaxoSmithKline Revenue in Herpes Simplex Virus Treatment Business (2014-2019)
12.9.5 GlaxoSmithKline Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details